Metro Treatment Of Florida, Lp | |
1497 Forest Hill Blvd Ste E Lake Clarke Shores FL 33406-6052 | |
(561) 433-5687 | |
(561) 433-5705 |
Full Name | Metro Treatment Of Florida, Lp |
---|---|
Speciality | Clinic/center - Methadone |
Location | 1497 Forest Hill Blvd Ste E, Lake Clarke Shores, Florida |
Authorized Official Name and Position | Sarah Chapman (PAYOR RELATIONS) |
Authorized Official Contact | 4073517080 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Metro Treatment Of Florida, Lp 2500 Maitland Center Pkwy Maitland FL 32751-7224 Ph: (407) 351-7080 | Metro Treatment Of Florida, Lp 1497 Forest Hill Blvd Ste E Lake Clarke Shores FL 33406-6052 Ph: (561) 433-5687 |
NPI Number | 1043090384 |
---|---|
Provider Enumeration Date | 10/04/2023 |
Last Update Date | 10/04/2023 |
Certification Date | 10/02/2023 |
Identifier | Type | State | Issuer |
---|---|---|---|
1043090384 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
251S00000X | Community/behavioral Health | (* (Not Available)) | Secondary |
261QM2800X | Clinic/center - Methadone | (* (Not Available)) | Primary |
News Archive
As millions of patients struggle with diseases that lack adequate treatments, there is a critical need to understand how existing drugs can be used in new ways to improve clinical outcomes.
Some useful drugs consist of peptides acting on their protein targets. To make them more efficient and stable, scientists have found a way to replace crucial segments of the peptides with ureido units.
GNYHA Services, Inc. and Essensa, Inc., leading group purchasing organizations serving acute care, alternate care, and non-healthcare markets, have added MedSnap ID to their portfolio of technology offerings.
A government scheme to support the mental health of people affected by terrorist attacks needs to provide a better system of immediate psychological help, according to research led by the Care Policy and Evaluation Centre at the London School of Economics and Political Science.
Today (8 January 2018) at the annual J.P. Morgan Healthcare Conference, Edico Genome and Genomics England announced a new partnership to strengthen the accuracy and consistency of next-generation sequencing data analysis in Genomics England's Rare Disease Pilot.
› Verified 6 days ago